A single-arm phase 2 study of peri-operative immune checkpoint inhibition and cryoablation in women with hormone receptor-negative, HER2-negative, early-stage/resectable breast cancer.

Authors

Heather McArthur

Heather L. McArthur

University of Texas Southwestern Medical Center, Dallas, TX

Heather L. McArthur , Elizabeth Anne Comen , Yolanda Bryce , Stephen Barnett Solomon , Jorge Henrique S. Leal , Christina DiLauro Abaya , Cristal Martinez , Reva K Basho , Philomena McAndrew , Brigid Larkin , David B. Page , Staci L. Mellinger , Nicole Fredrich , Nicole Moxon , Sangeetha M. Reddy , Meredith Carter , Sujata Patil , Basak Dogan , Margaret Elena Gatti-Mays , Larry Norton

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Breast Cancer—Local/Regional/Adjuvant

Track

Breast Cancer

Sub Track

Neoadjuvant Therapy

Clinical Trial Registration Number

NCT03546686

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr TPS635)

DOI

10.1200/JCO.2023.41.16_suppl.TPS635

Abstract #

TPS635

Poster Bd #

455a

Abstract Disclosures